WhatsApp and atopic dermatitis: a clinical trial.

ABSTRACT:

Objective

To evaluate the effect of text messages with information about atopic dermatitis (AD) on the quality of life (QoL) of children and their caregivers and on the severity of the disease.

Methods

Researcher-blinded randomized controlled clinical trial. The experimental group (EG) received messages about AD and the control group (CG) about general health. A total of 56 children under 15 years of age and their caregivers, allocated to the CG and EG, were assessed on admission, after one month, and after four months. Improvement in QoL was measured by the Children's Dermatology Life Quality Index (CDLQI), the Infants' Dermatitis Quality of Life Index (IDQOL), and the Dermatitis Family Impact Questionnaire (DFIQ), and improvement in the severity of AD by the Scoring of Ato

SUBMITTER: Cerqueira TB 

PROVIDER: S-EPMC11763882 | biostudies-literature | 2025 Jan-Feb

REPOSITORIES: biostudies-literature